These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 7927003)
21. Clinical features of atypical Kawasaki disease. Hsieh YC; Wu MH; Wang JK; Lee PI; Lee CY; Huang LM J Microbiol Immunol Infect; 2002 Mar; 35(1):57-60. PubMed ID: 11950122 [TBL] [Abstract][Full Text] [Related]
22. Lessons from Kawasaki disease: all brands of IVIG are not equal. Stiehm ER J Pediatr; 2006 Jan; 148(1):6-8. PubMed ID: 16423589 [No Abstract] [Full Text] [Related]
23. Is there a role for corticosteroids in Kawasaki disease? Shulman ST J Pediatr; 2003 Jun; 142(6):601-3. PubMed ID: 12838185 [No Abstract] [Full Text] [Related]
24. Kawasaki-like syndrome possibly associated with immune reconstitution inflammatory syndrome in an HIV-positive patient. Velez AP; Menezes L; Crespo A AIDS Read; 2006 Sep; 16(9):464-6. PubMed ID: 17024765 [TBL] [Abstract][Full Text] [Related]
25. The clinical efficacy of IVGG in Kawasaki disease. Rowley AH; Shulman ST Clin Rev Allergy; 1992; 10(1-2):81-91. PubMed ID: 1606526 [No Abstract] [Full Text] [Related]
26. Aspirin dose for treatment of Kawasaki disease. Krasemann T Arch Dis Child; 2015 Mar; 100(3):300. PubMed ID: 25409983 [No Abstract] [Full Text] [Related]
28. Differences in immunoglobulin preparations and outcome of Kawasaki disease. Yavuz H; Ozel A J Pediatr; 1996 May; 128(5 Pt 1):719-20. PubMed ID: 8627453 [No Abstract] [Full Text] [Related]
29. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease. Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408 [TBL] [Abstract][Full Text] [Related]
30. [Advance in diagnosis and treatment of intravenous immunogolobulin-resistant Kawasaki disease]. Zhang Q Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):318-21. PubMed ID: 19374823 [No Abstract] [Full Text] [Related]
31. Kawasaki disease: who is at risk? Newburger JW J Pediatr; 2000 Aug; 137(2):149-52. PubMed ID: 10931403 [No Abstract] [Full Text] [Related]
32. Authors' response to 'aspirin dose for treatment of Kawasaki disease'. Eleftheriou D; Levin M; Shingadia D; Tulloh R; Klein N; Brogan P Arch Dis Child; 2015 Mar; 100(3):300-1. PubMed ID: 25425602 [No Abstract] [Full Text] [Related]
33. [Effect of immunoglobulin in the prevention of coronary artery aneurysms in Kawasaki disease]. Chaker L; Drissa MA; Drissa H Tunis Med; 2009 Mar; 87(3):228-9. PubMed ID: 19537024 [No Abstract] [Full Text] [Related]
35. Incomplete Kawasaki disease: a pediatric diagnostic conflict. Celik U; Alhan E; Arabaci F Anadolu Kardiyol Derg; 2007 Sep; 7(3):343-4. PubMed ID: 17785242 [No Abstract] [Full Text] [Related]
36. Mechanisms of immunoglobulin action: observations on Kawasaki syndrome and RSV prophylaxis. Meissner HC; Schlievert PM; Leung DY Immunol Rev; 1994 Jun; 139():109-23. PubMed ID: 7927408 [No Abstract] [Full Text] [Related]
37. Fever and erythema in the emergency room. Hughey LC Semin Cutan Med Surg; 2007 Sep; 26(3):133-8. PubMed ID: 18070679 [TBL] [Abstract][Full Text] [Related]
38. A child with prolonged pyrexia and peripheral desquamation: is it Kawasaki disease? Mitra S; Singh S; Grover A; Kumar L Indian Pediatr; 2000 Jul; 37(7):786-9. PubMed ID: 10906815 [No Abstract] [Full Text] [Related]
39. Kawasaki disease in a US army soldier highlights surveillance. Chang C; Wood JC; Strickling WA; Walsh DS Int J Dermatol; 2006 Jan; 45(1):83-4. PubMed ID: 16426385 [No Abstract] [Full Text] [Related]